Prime Medicine, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -3.44M-165.35M-121.82M-198.13M-195.88M
Share-based Compensation 0.39M1.75M6.46M13.91M26.07M
Deferred Taxes 1.87M-0.62M-0.96M-0.28M
Gains from Investment Securities 0.13M12.26M28.59M3.27M44.94M
Cash from Operations -5.54M-34.08M-131.83M-165.41M-122.86M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 4.29M9.79M12.79M12.36M
Depreciation & Amortization (CF) 0.04M0.60M2.22M4.65M6.13M
Change in Working Capital
Change in Account Payables 0.25M1.19M2.46M9.14M-5.26M
Change in Accured Expenses 0.30M35.21M-25.87M1.76M1.84M
Investing Activities
Capital Expenditures 0.64M4.15M16.09M8.72M7.29M
Change in Acquisitions & Divestments 13.00M93.00M132.56M204.20M
Cash from Investing Activities -1.06M-73.63M-47.10M18.71M68.46M
Financing Activities
Other financing activities 0.02M1.09M4.04M
Change in Capital Stock
Shares Issued 185.32M0.66M38.08M
Preferred Shares Issued 34.95M199.64M
Misc.
Cash from Financing Activities 34.93M269.28M181.49M0.66M195.88M
Change in Cash 28.33M161.57M2.57M-146.05M141.47M
Free Cash Flow -6.18M-38.23M-147.92M-174.14M-130.16M
Net Cash Flow 28.33M161.57M2.57M-146.05M141.47M